Valuing Health Technologies at NICE

Recommendations for Improved Incorporation of Treatment Value in HTA

Published in: Health Economics, v. 19, no. 10, Oct. 2010, Editorial, p. 1109-1116

by Dana P. Goldman, Darius N. Lakdawalla, Tomas Philipson, Wesley Yin

Read More

Access further information on this document at

This article was published outside of RAND. The full text of the article can be found at the link above.

The method currently used to value new health-care treatments in the UK does not adequately capture some dimensions of the full costs and benefits of those treatments to the citizenry supporting the National Health Service.

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.